NO981241L - Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse - Google Patents

Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse

Info

Publication number
NO981241L
NO981241L NO981241A NO981241A NO981241L NO 981241 L NO981241 L NO 981241L NO 981241 A NO981241 A NO 981241A NO 981241 A NO981241 A NO 981241A NO 981241 L NO981241 L NO 981241L
Authority
NO
Norway
Prior art keywords
optionally substituted
derivatives
pharmaceutical preparations
preparations containing
heteroaryl substituted
Prior art date
Application number
NO981241A
Other languages
English (en)
Norwegian (no)
Other versions
NO981241D0 (no
Inventor
Kazumi Kikuchi
Akira Toyoshima
Toshio Okazaki
Masahiro Takanashi
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO981241D0 publication Critical patent/NO981241D0/no
Publication of NO981241L publication Critical patent/NO981241L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO981241A 1995-09-20 1998-03-19 Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse NO981241L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24171695 1995-09-20
PCT/JP1996/002696 WO1997011055A1 (fr) 1995-09-20 1996-09-19 Derives d'acryloylguanidine a substitution heteroaryle et leurs composition medicinale

Publications (2)

Publication Number Publication Date
NO981241D0 NO981241D0 (no) 1998-03-19
NO981241L true NO981241L (no) 1998-05-20

Family

ID=17078479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981241A NO981241L (no) 1995-09-20 1998-03-19 Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse

Country Status (13)

Country Link
EP (1) EP0861831A4 (sk)
KR (1) KR19990063589A (sk)
CN (1) CN1196721A (sk)
AU (1) AU702092B2 (sk)
BR (1) BR9610530A (sk)
CA (1) CA2232497A1 (sk)
CZ (1) CZ84098A3 (sk)
HU (1) HUP9901336A3 (sk)
NO (1) NO981241L (sk)
PL (1) PL326033A1 (sk)
SK (1) SK35198A3 (sk)
WO (1) WO1997011055A1 (sk)
ZA (1) ZA967800B (sk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854721B1 (en) * 1995-08-02 2001-10-24 Smithkline Beecham Corporation Endothelin receptor antagonists
US6258829B1 (en) * 1997-03-06 2001-07-10 Toa Eiyo Ltd. Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
EP1206464A4 (en) * 1999-08-23 2002-12-18 Smithkline Beecham Corp FATTY ACID SYNTHASE INHIBITORS
WO2002051441A1 (fr) * 2000-12-26 2002-07-04 Sankyo Company, Limited Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
TW200602045A (en) 2004-06-16 2006-01-16 Wyeth Corp Amino-5, 5-diphenylimidazolone derivatives for the inhibition of β-secretase
EP1758907B1 (en) 2004-06-16 2009-02-18 Wyeth Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase
JP2008526966A (ja) 2005-01-14 2008-07-24 ワイス β−セクレターゼの阻害のためのアミノ−イミダゾロン
BRPI0607094A2 (pt) 2005-02-01 2009-08-04 Wyeth Corp composto da fórmula i; uso do composto para o tratamento de uma doença ou distúrbio associado à atividade excessiva de bace em um paciente que dele necessita; uso do composto para modular a atividade de bace; e composição farmacêutica
WO2006088694A1 (en) 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
CN101146769A (zh) 2005-02-14 2008-03-19 惠氏公司 作为β-分泌酶抑制剂的唑基酰基胍
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
EP1896448A1 (en) 2005-06-30 2008-03-12 Wyeth AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION
PE20070461A1 (es) 2005-09-26 2007-05-10 Wyeth Corp Compuestos de amino-5-[4-(difluorometoxi)fenil]-5-fenilimidazolona como inhibidores de b-secretasa
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
AR065814A1 (es) 2007-03-23 2009-07-01 Wyeth Corp Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados.
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
JP3162572B2 (ja) * 1993-04-28 2001-05-08 住友製薬株式会社 インドロイルグアニジン誘導体
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
JPH0959245A (ja) * 1995-08-25 1997-03-04 Yamanouchi Pharmaceut Co Ltd N−(2−プロペノイル)グアニジン誘導体

Also Published As

Publication number Publication date
BR9610530A (pt) 1999-07-06
NO981241D0 (no) 1998-03-19
HUP9901336A3 (en) 2000-02-28
MX9802238A (es) 1998-08-30
CZ84098A3 (cs) 1998-09-16
ZA967800B (en) 1997-04-03
CN1196721A (zh) 1998-10-21
WO1997011055A1 (fr) 1997-03-27
EP0861831A4 (en) 1998-11-11
HUP9901336A2 (hu) 1999-08-30
EP0861831A1 (en) 1998-09-02
SK35198A3 (en) 1999-06-11
PL326033A1 (en) 1998-08-17
CA2232497A1 (en) 1997-03-27
AU702092B2 (en) 1999-02-11
KR19990063589A (ko) 1999-07-26
AU7000796A (en) 1997-04-09

Similar Documents

Publication Publication Date Title
NO981241L (no) Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DK1136474T3 (da) 1-Acetyl-5-brom-4,6-dimethylindolin
ES471981A1 (es) Un procedimiento para la preparacion de derivados de imida- zoquinazolina
EE200000545A (et) Benseensulfoonamiidide derivaadid ja nende kasutamine ravimitena
ES476496A1 (es) Procedimiento para preparar derivados de acido ftalazin-4- ilacetico.
FR2401159A1 (fr) Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique
NO963506L (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
MY8700552A (en) Derivatives-of 3-aminopropane-1,2-diol processes for their preparation pharmaceutical preparations containing such compounds & the use of the latter
SE8303824D0 (sv) N-imidazolyl derivatives of bicyclic compounds and process for their preparation
ATE60579T1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
RU95100773A (ru) Новые сложные эфиры серной кислоты сахарных спиртов
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
DE69103630D1 (de) Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.
NO920432L (no) Cykloalkylenazoler, fremgangsmaate for fremstilling av disse, farmasoeytiske preparater som inneholder disse, saavel som deres anvendelse for fremstilling av legemidler
NO20022456L (no) Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon
AU7812087A (en) Benzhydryloxyethylpiperidine derivatives, process for their preparation and pharmaceutical compositions in which they are present
AR004680A1 (es) Derivados de la alquenil-benzoilguanidina, procedimiento para prepararlos y preparaciones farmaceuticas que los contienen.
MY103236A (en) Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing them
DK176788A (da) Thienyloxyeddikesyrederivater, fremgangsmaade til fremstilling af saadanne derivater og laegemiddel indeholdende disse
TH20764A (th) อนุพันธ์เฮเทอโรไซคลิคของแอไซโลน